Analysis HIE Meaningful Use mHealth 
Chilmark Research
APRIL 3, 2013
mHealth, known for rapid innovation and iteration, has a tendency to buck at the snail’s pace of FDA regulation. This could herald a new age of credibility for mHealth. They will need to tread carefully to maintain their objectivity in both certifying apps while at the same time providing a marketplace for mHealth apps.
Chilmark Research
MARCH 6, 2014
HIE vendors are looking to build out patient portals and care coordination applications as they transition from building pipelines to demonstrating value. Instead of looking ahead, HIE vendors are looking at MU2 and assembling a new crop of anemic patient portals that allow VDT and little else. HIEs Look Backward.
The Digital Health Corner
JUNE 14, 2017
A landmark clinical trial in which drugs are given solely on the basis of genetic markers identified in the cancer tissue itself is the NCI-MATCH Trial (Molecular Analysis for Therapy Choice). There are hospitals within the same healthcare system in many places with disparate EHRs which do not talk to each other or exchange information.
Expert insights. Personalized for you.
60 
Let's personalize your content